Captrust Financial Advisors »

Mink Therapeutics shares owned by Captrust Financial Advisors

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Captrust Financial Advisors from 13F filings

Historical chart of Captrust Financial Advisors investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Captrust Financial Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $58k 54k 1.07
2023-09-30 $68k 62k 1.10
2023-06-30 $83k 40k 2.10

More positions owned by Captrust Financial Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Vanguard Value Etf (VTV)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
Ishares Ibonds Dec 2024 Term Treasury Etf Etf (IBTE)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard S&p 500 Etf Etf (VOO)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Technology Select Sector Spdr Fund Etf (XLK)
Amazon Stock (AMZN)
Ishares Ibonds Dec 2025 Term Treasury Etf Etf (IBTF)

View all positions for Captrust Financial Advisors

Top funds holding Mink Therapeutics

Vanguard Group
Longbow Finance SA
Captrust Financial Advisors
HighTower Advisors
Citadel Advisors
Oracle Investment Management
Bank of America Corporation
Goldman Sachs Group
Jane Street
Wells Fargo & Company
Virtu Financial
UBS Group
Artal Group
Covestor
Royal Bank of Canada

View all funds holding Mink Therapeutics